| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | sodium:bicarbonate symporter activity | 2.00e-06 | 6 | 94 | 3 | GO:0008510 | |
| GeneOntologyMolecularFunction | nucleocytoplasmic carrier activity | 1.50e-05 | 32 | 94 | 4 | GO:0140142 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 1.63e-05 | 171 | 94 | 7 | GO:0015103 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.97e-05 | 70 | 94 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | aromatase activity | 2.16e-05 | 35 | 94 | 4 | GO:0070330 | |
| GeneOntologyMolecularFunction | oxygen binding | 2.70e-05 | 37 | 94 | 4 | GO:0019825 | |
| GeneOntologyMolecularFunction | monoatomic cation:bicarbonate symporter activity | 2.79e-05 | 13 | 94 | 3 | GO:0140410 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 3.56e-05 | 193 | 94 | 7 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 4.05e-05 | 197 | 94 | 7 | GO:0022834 | |
| GeneOntologyMolecularFunction | sodium,bicarbonate:chloride antiporter activity | 6.56e-05 | 3 | 94 | 2 | GO:0140892 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 7.83e-05 | 18 | 94 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 7.97e-05 | 151 | 94 | 6 | GO:0008509 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 8.30e-05 | 49 | 94 | 4 | GO:0016712 | |
| GeneOntologyMolecularFunction | signal sequence binding | 9.71e-05 | 51 | 94 | 4 | GO:0005048 | |
| GeneOntologyMolecularFunction | nuclear import signal receptor activity | 1.09e-04 | 20 | 94 | 3 | GO:0061608 | |
| GeneOntologyMolecularFunction | testosterone 6-beta-hydroxylase activity | 2.17e-04 | 5 | 94 | 2 | GO:0050649 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | ANO9 TRPC4AP SLC4A7 SLC4A8 TRPM5 KCNA10 KCNH2 GLRA2 TTYH2 SLC4A10 AQP6 KCNT1 | 2.26e-04 | 758 | 94 | 12 | GO:0015318 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 2.39e-04 | 118 | 94 | 5 | GO:0003774 | |
| GeneOntologyMolecularFunction | RNA polymerase binding | 2.50e-04 | 65 | 94 | 4 | GO:0070063 | |
| GeneOntologyMolecularFunction | nuclear localization sequence binding | 2.72e-04 | 27 | 94 | 3 | GO:0008139 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 3.04e-04 | 28 | 94 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 3.12e-04 | 125 | 94 | 5 | GO:0015108 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ANO9 TRPC4AP SLC4A7 SLC4A8 TRPM5 KCNA10 KCNH2 SLCO2A1 GLRA2 TTYH2 SLC19A2 SLC4A10 SLC35B2 AQP6 KCNT1 | 3.90e-04 | 1180 | 94 | 15 | GO:0022857 |
| GeneOntologyMolecularFunction | bicarbonate transmembrane transporter activity | 4.54e-04 | 32 | 94 | 3 | GO:0015106 | |
| GeneOntologyMolecularFunction | solute:inorganic anion antiporter activity | 4.54e-04 | 32 | 94 | 3 | GO:0005452 | |
| GeneOntologyMolecularFunction | estrogen 2-hydroxylase activity | 6.03e-04 | 8 | 94 | 2 | GO:0101021 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 6.99e-04 | 37 | 94 | 3 | GO:0045505 | |
| GeneOntologyMolecularFunction | channel activity | 8.23e-04 | 525 | 94 | 9 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 8.34e-04 | 526 | 94 | 9 | GO:0022803 | |
| GeneOntologyMolecularFunction | transporter activity | ANO9 TRPC4AP SLC4A7 SLC4A8 TRPM5 KCNA10 KCNH2 SLCO2A1 GLRA2 TTYH2 SLC19A2 SLC4A10 SLC35B2 AQP6 KCNT1 | 9.72e-04 | 1289 | 94 | 15 | GO:0005215 |
| GeneOntologyMolecularFunction | gated channel activity | 1.01e-03 | 334 | 94 | 7 | GO:0022836 | |
| GeneOntologyMolecularFunction | estrogen 16-alpha-hydroxylase activity | 1.17e-03 | 11 | 94 | 2 | GO:0101020 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | ANO9 TRPC4AP SLC4A7 SLC4A8 TRPM5 KCNA10 KCNH2 GLRA2 TTYH2 SLC4A10 KCNT1 | 1.24e-03 | 793 | 94 | 11 | GO:0015075 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 1.45e-03 | 459 | 94 | 8 | GO:0005216 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 1.58e-03 | 465 | 94 | 8 | GO:0046873 | |
| GeneOntologyMolecularFunction | chloride:bicarbonate antiporter activity | 1.65e-03 | 13 | 94 | 2 | GO:0140900 | |
| GeneOntologyMolecularFunction | bicarbonate:monoatomic anion antiporter activity | 1.65e-03 | 13 | 94 | 2 | GO:0140829 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 1.69e-03 | 50 | 94 | 3 | GO:0099095 | |
| GeneOntologyMolecularFunction | molecular carrier activity | 1.70e-03 | 108 | 94 | 4 | GO:0140104 | |
| GeneOntologyMolecularFunction | retinoic acid 4-hydroxylase activity | 1.92e-03 | 14 | 94 | 2 | GO:0008401 | |
| GeneOntologyMolecularFunction | monooxygenase activity | 2.14e-03 | 115 | 94 | 4 | GO:0004497 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 2.62e-03 | 293 | 94 | 6 | GO:0008514 | |
| GeneOntologyMolecularFunction | potassium channel activity | 3.15e-03 | 128 | 94 | 4 | GO:0005267 | |
| GeneOntologyMolecularFunction | microtubule binding | 3.36e-03 | 308 | 94 | 6 | GO:0008017 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | KIF21B ERCC6 DNAH12 KIF12 TWNK GNAT1 GNAT2 DNAH9 ENTPD4 OPA1 | 3.50e-03 | 775 | 94 | 10 | GO:0017111 |
| GeneOntologyMolecularFunction | intracellularly calcium-gated channel activity | 3.94e-03 | 20 | 94 | 2 | GO:0141147 | |
| GeneOntologyMolecularFunction | intracellularly calcium-gated chloride channel activity | 3.94e-03 | 20 | 94 | 2 | GO:0005229 | |
| GeneOntologyMolecularFunction | tubulin binding | 4.09e-03 | 428 | 94 | 7 | GO:0015631 | |
| GeneOntologyMolecularFunction | antiporter activity | 4.12e-03 | 138 | 94 | 4 | GO:0015297 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 4.34e-03 | 140 | 94 | 4 | GO:0099094 | |
| GeneOntologyMolecularFunction | heme binding | 6.06e-03 | 154 | 94 | 4 | GO:0020037 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | KIF21B ERCC6 DNAH12 KIF12 TWNK GNAT1 GNAT2 DNAH9 ENTPD4 OPA1 | 6.08e-03 | 839 | 94 | 10 | GO:0016462 |
| GeneOntologyMolecularFunction | G-protein beta/gamma-subunit complex binding | 6.13e-03 | 25 | 94 | 2 | GO:0031683 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | KIF21B ERCC6 DNAH12 KIF12 TWNK GNAT1 GNAT2 DNAH9 ENTPD4 OPA1 | 6.13e-03 | 840 | 94 | 10 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | KIF21B ERCC6 DNAH12 KIF12 TWNK GNAT1 GNAT2 DNAH9 ENTPD4 OPA1 | 6.13e-03 | 840 | 94 | 10 | GO:0016818 |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 6.61e-03 | 81 | 94 | 3 | GO:0015370 | |
| GeneOntologyMolecularFunction | tetrapyrrole binding | 7.55e-03 | 164 | 94 | 4 | GO:0046906 | |
| GeneOntologyMolecularFunction | delayed rectifier potassium channel activity | 7.65e-03 | 28 | 94 | 2 | GO:0005251 | |
| GeneOntologyMolecularFunction | chloride channel activity | 7.80e-03 | 86 | 94 | 3 | GO:0005254 | |
| GeneOntologyMolecularFunction | iron ion binding | 7.87e-03 | 166 | 94 | 4 | GO:0005506 | |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 8.03e-03 | 167 | 94 | 4 | GO:0015079 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 8.39e-03 | 614 | 94 | 8 | GO:0140657 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 8.71e-03 | 171 | 94 | 4 | GO:0015081 | |
| GeneOntologyMolecularFunction | monoatomic ion-gated channel activity | 9.33e-03 | 31 | 94 | 2 | GO:0022839 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 9.45e-03 | 627 | 94 | 8 | GO:0022890 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | ANO9 TRPC4AP SLC4A7 SLC4A8 TRPM5 THY1 PSEN2 KCNA10 KCNH2 GLRA2 DHRS7C TTYH2 SLC4A10 PLCB3 AQP6 KCNT1 OPA1 | 3.06e-06 | 1017 | 94 | 17 | GO:0098660 |
| GeneOntologyBiologicalProcess | inorganic anion transport | 1.85e-05 | 180 | 94 | 7 | GO:0015698 | |
| GeneOntologyBiologicalProcess | background adaptation | 2.05e-05 | 2 | 94 | 2 | GO:0120302 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | ANO9 TRPC4AP SLC4A7 SLC4A8 TRPM5 THY1 PSEN2 KCNA10 KCNH2 GLRA2 DHRS7C TTYH2 SLC4A10 PLCB3 KCNT1 OPA1 | 4.08e-05 | 1115 | 94 | 16 | GO:0034220 |
| GeneOntologyBiologicalProcess | neural tissue regeneration | 6.15e-05 | 3 | 94 | 2 | GO:0097719 | |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 7.18e-05 | 153 | 94 | 6 | GO:0098656 | |
| GeneOntologyBiologicalProcess | camera-type eye photoreceptor cell differentiation | 7.32e-05 | 49 | 94 | 4 | GO:0060219 | |
| GeneOntologyBiologicalProcess | retinal cone cell differentiation | 1.33e-04 | 22 | 94 | 3 | GO:0042670 | |
| GeneOntologyBiologicalProcess | monoatomic anion transport | 1.92e-04 | 183 | 94 | 6 | GO:0006820 | |
| GeneOntologyBiologicalProcess | basolateral protein secretion | 2.04e-04 | 5 | 94 | 2 | GO:0110010 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | TRPC4AP SLC4A7 SLC4A8 TRPM5 THY1 PSEN2 KCNA10 KCNH2 DHRS7C SLC4A10 PLCB3 KCNT1 OPA1 | 2.75e-04 | 922 | 94 | 13 | GO:0098662 |
| GeneOntologyBiologicalProcess | chloride transport | 3.00e-04 | 128 | 94 | 5 | GO:0006821 | |
| GeneOntologyBiologicalProcess | microtubule-based process | KIF21B XRN2 RIPOR2 KATNBL1 DNAH12 DNAH17 KIF12 CCDC187 RSPH6A NEDD1 DNAH9 ARMCX3 OPA1 CFAP157 | 3.01e-04 | 1058 | 94 | 14 | GO:0007017 |
| GeneOntologyBiologicalProcess | eye photoreceptor cell differentiation | 3.28e-04 | 72 | 94 | 4 | GO:0001754 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | TRPC4AP SLC4A7 SLC4A8 TRPM5 THY1 PSEN2 KCNA10 KCNH2 DHRS7C SLC4A10 PLCB3 KCNT1 OPA1 | 3.38e-04 | 942 | 94 | 13 | GO:0098655 |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | TTC7A NPY1R DRD5 SLC4A7 SLC4A8 THY1 PSEN2 KCNH2 DHRS7C SLC4A10 PLCB3 | 3.61e-04 | 705 | 94 | 11 | GO:0055080 |
| GeneOntologyBiologicalProcess | inorganic anion transmembrane transport | 3.71e-04 | 134 | 94 | 5 | GO:0098661 | |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | TTC7A NPY1R DRD5 SLC4A7 SLC4A8 THY1 PSEN2 KCNH2 DHRS7C SLC4A10 PLCB3 | 4.16e-04 | 717 | 94 | 11 | GO:0050801 |
| GeneOntologyBiologicalProcess | microtubule-based movement | 4.17e-04 | 493 | 94 | 9 | GO:0007018 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway coupled to cGMP nucleotide second messenger | 4.25e-04 | 7 | 94 | 2 | GO:0007199 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | ANO9 TRPC4AP SLC4A7 SLC4A8 TRPM5 THY1 PSEN2 KCNA10 KCNH2 GLRA2 DHRS7C TTYH2 SLC4A10 PLCB3 KCNT1 OPA1 | 4.51e-04 | 1374 | 94 | 16 | GO:0006811 |
| GeneOntologyBiologicalProcess | intracellular monoatomic cation homeostasis | TTC7A NPY1R DRD5 SLC4A7 SLC4A8 THY1 PSEN2 DHRS7C SLC4A10 PLCB3 | 4.68e-04 | 611 | 94 | 10 | GO:0030003 |
| GeneOntologyBiologicalProcess | intracellular monoatomic ion homeostasis | TTC7A NPY1R DRD5 SLC4A7 SLC4A8 THY1 PSEN2 DHRS7C SLC4A10 PLCB3 | 5.37e-04 | 622 | 94 | 10 | GO:0006873 |
| GeneOntologyBiologicalProcess | intracellular chemical homeostasis | TTC7A NPY1R DRD5 SLC4A7 SLC4A8 THY1 PSEN2 TBC1D1 DHRS7C SLC4A10 TWNK PLCB3 | 5.61e-04 | 866 | 94 | 12 | GO:0055082 |
| GeneOntologyCellularComponent | microtubule associated complex | 8.85e-05 | 161 | 94 | 6 | GO:0005875 | |
| GeneOntologyCellularComponent | cilium | TNPO1 CD52 DRD5 DNAH12 PSEN2 DNAH17 PTPN23 RSPH6A GNAT1 GNAT2 NEDD1 DNAH9 CFAP157 | 1.87e-04 | 898 | 94 | 13 | GO:0005929 |
| GeneOntologyCellularComponent | axonemal dynein complex | 1.88e-04 | 25 | 94 | 3 | GO:0005858 | |
| Domain | ARM-type_fold | TNPO1 IPO5 TRPC4AP RIPOR2 AP1B1 AP2B1 TELO2 XPO6 TNPO2 UBR4 EIF4G1 NBEA WDFY3 ARMCX3 | 9.77e-10 | 339 | 91 | 14 | IPR016024 |
| Domain | ARM-like | TNPO1 IPO5 RIPOR2 KATNBL1 AP1B1 AP2B1 TELO2 XPO6 TNPO2 NBEA WDFY3 ARMCX3 | 7.47e-09 | 270 | 91 | 12 | IPR011989 |
| Domain | - | 1.28e-07 | 222 | 91 | 10 | 1.25.10.10 | |
| Domain | IMPORTIN_B_NT | 5.09e-07 | 14 | 91 | 4 | PS50166 | |
| Domain | Importin-beta_N | 1.20e-06 | 17 | 91 | 4 | IPR001494 | |
| Domain | ANION_EXCHANGER_2 | 3.86e-06 | 7 | 91 | 3 | PS00220 | |
| Domain | ANION_EXCHANGER_1 | 3.86e-06 | 7 | 91 | 3 | PS00219 | |
| Domain | Band3_cytoplasmic_dom | 9.20e-06 | 9 | 91 | 3 | IPR013769 | |
| Domain | Band_3_cyto | 9.20e-06 | 9 | 91 | 3 | PF07565 | |
| Domain | - | 9.20e-06 | 9 | 91 | 3 | 3.40.1100.10 | |
| Domain | HCO3_cotransp | 1.31e-05 | 10 | 91 | 3 | PF00955 | |
| Domain | HCO3_transpt_C | 1.31e-05 | 10 | 91 | 3 | IPR011531 | |
| Domain | PTrfase/Anion_transptr | 1.31e-05 | 10 | 91 | 3 | IPR016152 | |
| Domain | HCO3_transpt_euk | 1.31e-05 | 10 | 91 | 3 | IPR003020 | |
| Domain | - | 2.35e-05 | 2 | 91 | 2 | 2.60.40.1150 | |
| Domain | Clathrin_b-adaptin_app_Ig-like | 2.35e-05 | 2 | 91 | 2 | IPR013037 | |
| Domain | IBN_N | 4.88e-05 | 15 | 91 | 3 | PF03810 | |
| Domain | IBN_N | 5.98e-05 | 16 | 91 | 3 | SM00913 | |
| Domain | AP_complex_bsu_1_2_4 | 7.02e-05 | 3 | 91 | 2 | IPR016342 | |
| Domain | B2-adapt-app_C | 7.02e-05 | 3 | 91 | 2 | PF09066 | |
| Domain | Armadillo | 8.01e-05 | 47 | 91 | 4 | IPR000225 | |
| Domain | Cyt_P450_CS | 1.29e-04 | 53 | 91 | 4 | IPR017972 | |
| Domain | B-adaptin_app_sub_C | 1.40e-04 | 4 | 91 | 2 | IPR015151 | |
| Domain | B2-adapt-app_C | 1.40e-04 | 4 | 91 | 2 | SM01020 | |
| Domain | CYTOCHROME_P450 | 1.71e-04 | 57 | 91 | 4 | PS00086 | |
| Domain | p450 | 1.83e-04 | 58 | 91 | 4 | PF00067 | |
| Domain | Cyt_P450 | 2.09e-04 | 60 | 91 | 4 | IPR001128 | |
| Domain | Cyt_P450_E_grp-II | 2.33e-04 | 5 | 91 | 2 | IPR002402 | |
| Domain | AP_beta | 2.33e-04 | 5 | 91 | 2 | IPR026739 | |
| Domain | Anion_exchange | 2.33e-04 | 5 | 91 | 2 | IPR001717 | |
| Domain | DUF4704 | 2.33e-04 | 5 | 91 | 2 | IPR031570 | |
| Domain | DUF4704 | 2.33e-04 | 5 | 91 | 2 | PF15787 | |
| Domain | Na/HCO3_transpt | 2.33e-04 | 5 | 91 | 2 | IPR003024 | |
| Domain | Cyt_P450_E_CYP3A | 3.48e-04 | 6 | 91 | 2 | IPR008072 | |
| Domain | PH_BEACH | 3.48e-04 | 6 | 91 | 2 | PF14844 | |
| Domain | Beta2_adaptin/TBP_C_dom | 3.48e-04 | 6 | 91 | 2 | IPR012295 | |
| Domain | - | 3.48e-04 | 6 | 91 | 2 | 3.30.310.10 | |
| Domain | PH-BEACH_dom | 6.45e-04 | 8 | 91 | 2 | IPR023362 | |
| Domain | Coatomer/calthrin_app_sub_C | 6.45e-04 | 8 | 91 | 2 | IPR009028 | |
| Domain | Gprotein_alpha_I | 6.45e-04 | 8 | 91 | 2 | IPR001408 | |
| Domain | - | 6.45e-04 | 8 | 91 | 2 | 2.30.29.40 | |
| Domain | PH_BEACH | 6.45e-04 | 8 | 91 | 2 | PS51783 | |
| Domain | Clathrin_a/b/g-adaptin_app_Ig | 8.27e-04 | 9 | 91 | 2 | IPR008152 | |
| Domain | BEACH_dom | 8.27e-04 | 9 | 91 | 2 | IPR000409 | |
| Domain | Alpha_adaptinC2 | 8.27e-04 | 9 | 91 | 2 | PF02883 | |
| Domain | BEACH | 8.27e-04 | 9 | 91 | 2 | PS50197 | |
| Domain | Alpha_adaptinC2 | 8.27e-04 | 9 | 91 | 2 | SM00809 | |
| Domain | Beach | 8.27e-04 | 9 | 91 | 2 | PF02138 | |
| Domain | - | 8.27e-04 | 9 | 91 | 2 | 1.10.1540.10 | |
| Domain | Beach | 8.27e-04 | 9 | 91 | 2 | SM01026 | |
| Domain | Cyt_P450_E_grp-I | 1.37e-03 | 45 | 91 | 3 | IPR002401 | |
| Domain | Coatomer/clathrin_app_Ig-like | 1.50e-03 | 12 | 91 | 2 | IPR013041 | |
| Domain | HEAT | 1.65e-03 | 48 | 91 | 3 | PF02985 | |
| Domain | Dynein_heavy_chain_D4_dom | 2.06e-03 | 14 | 91 | 2 | IPR024317 | |
| Domain | Dynein_heavy_dom-2 | 2.06e-03 | 14 | 91 | 2 | IPR013602 | |
| Domain | DHC_N2 | 2.06e-03 | 14 | 91 | 2 | PF08393 | |
| Domain | AAA_8 | 2.06e-03 | 14 | 91 | 2 | PF12780 | |
| Domain | ATPase_dyneun-rel_AAA | 2.06e-03 | 14 | 91 | 2 | IPR011704 | |
| Domain | AAA_5 | 2.06e-03 | 14 | 91 | 2 | PF07728 | |
| Domain | DHC_fam | 2.37e-03 | 15 | 91 | 2 | IPR026983 | |
| Domain | Clathrin/coatomer_adapt-like_N | 2.37e-03 | 15 | 91 | 2 | IPR002553 | |
| Domain | Adaptin_N | 2.37e-03 | 15 | 91 | 2 | PF01602 | |
| Domain | Dynein_heavy_dom | 2.37e-03 | 15 | 91 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 2.37e-03 | 15 | 91 | 2 | PF03028 | |
| Domain | G-alpha | 2.70e-03 | 16 | 91 | 2 | PF00503 | |
| Domain | GproteinA_insert | 2.70e-03 | 16 | 91 | 2 | IPR011025 | |
| Domain | - | 2.70e-03 | 16 | 91 | 2 | 1.10.400.10 | |
| Domain | G_alpha | 2.70e-03 | 16 | 91 | 2 | SM00275 | |
| Domain | P-loop_NTPase | KIF21B NWD1 ERCC6 DNAH12 SMARCA1 KIF12 TWNK GNAT1 GNAT2 DNAH9 OPA1 | 2.73e-03 | 848 | 91 | 11 | IPR027417 |
| Domain | - | 2.84e-03 | 58 | 91 | 3 | 1.10.630.10 | |
| Domain | HEAT | 2.84e-03 | 58 | 91 | 3 | IPR000357 | |
| Domain | Gprotein_alpha_su | 3.04e-03 | 17 | 91 | 2 | IPR001019 | |
| Domain | WD40_repeat_dom | 3.31e-03 | 297 | 91 | 6 | IPR017986 | |
| Domain | HEAT_REPEAT | 4.84e-03 | 70 | 91 | 3 | PS50077 | |
| Pathway | REACTOME_BICARBONATE_TRANSPORTERS | 2.05e-05 | 10 | 80 | 3 | M27335 | |
| Pathway | REACTOME_BICARBONATE_TRANSPORTERS | 2.05e-05 | 10 | 80 | 3 | MM15073 | |
| Pubmed | TNPO1 IPO5 XRN2 NOP56 AP1B1 AP2B1 TELO2 CTR9 UBR4 EIF4G1 PTPN23 LRRC40 PKN2 NUP160 | 2.21e-09 | 638 | 95 | 14 | 33239621 | |
| Pubmed | TNPO1 IPO5 UBE4A AP1B1 AP2B1 TELO2 CTR9 TNPO2 EIF4G1 LRRC40 NUP160 OPA1 COG8 | 4.46e-09 | 560 | 95 | 13 | 35241646 | |
| Pubmed | 1.97e-07 | 5 | 95 | 3 | 23500099 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | TNPO1 IPO5 TRPC4AP AP1B1 AP2B1 TELO2 CTR9 UBR4 PTPN23 PTPRU NEDD1 ARMCX3 NUP160 OPA1 | 4.14e-07 | 974 | 95 | 14 | 28675297 |
| Pubmed | KIF21B SLC4A8 NOP56 AP1B1 AP2B1 SRGAP3 UBR4 EIF4G1 GIGYF2 NBEA WDFY3 KCNT1 OPA1 | 2.23e-06 | 963 | 95 | 13 | 28671696 | |
| Pubmed | 2.95e-06 | 225 | 95 | 7 | 12168954 | ||
| Pubmed | IPO5 XRN2 AGO4 PSEN2 NOP56 AP2B1 UBR4 MARCHF6 EIF4G1 GIGYF2 LRRC40 KDSR OPA1 COG8 | 3.48e-06 | 1168 | 95 | 14 | 19946888 | |
| Pubmed | 4.05e-06 | 449 | 95 | 9 | 31732153 | ||
| Pubmed | 4.23e-06 | 87 | 95 | 5 | 12465718 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | IPO5 SLC4A7 NOP56 AP1B1 AP2B1 CTR9 UBR4 EIF4G1 GIGYF2 PTPN23 LRRC40 PKN2 PLCB3 ARMCX3 OPA1 | 6.67e-06 | 1415 | 95 | 15 | 28515276 |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 28986474 | ||
| Pubmed | Adaptation to background light enables contrast coding at rod bipolar cell synapses. | 7.38e-06 | 2 | 95 | 2 | 24373883 | |
| Pubmed | Diminished Cone Sensitivity in cpfl3 Mice Is Caused by Defective Transducin Signaling. | 7.38e-06 | 2 | 95 | 2 | 32315379 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 2534964 | ||
| Pubmed | K+-Driven Cl-/HCO3- Exchange Mediated by Slc4a8 and Slc4a10. | 7.38e-06 | 2 | 95 | 2 | 38674160 | |
| Pubmed | Phototransduction in transgenic mice after targeted deletion of the rod transducin alpha -subunit. | 7.38e-06 | 2 | 95 | 2 | 11095744 | |
| Pubmed | Differential regulation of CYP3A4 and CYP3A7 by dimethylsulfoxide in primary human hepatocytes. | 7.38e-06 | 2 | 95 | 2 | 15379787 | |
| Pubmed | Transportin-1 and Transportin-2: protein nuclear import and beyond. | 7.38e-06 | 2 | 95 | 2 | 24780099 | |
| Pubmed | Dark light, rod saturation, and the absolute and incremental sensitivity of mouse cone vision. | 7.38e-06 | 2 | 95 | 2 | 20844144 | |
| Pubmed | Speed, spatial, and temporal tuning of rod and cone vision in mouse. | 7.38e-06 | 2 | 95 | 2 | 18171936 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 26772622 | ||
| Pubmed | Role of Chromatin Structural Changes in Regulating Human CYP3A Ontogeny. | 7.38e-06 | 2 | 95 | 2 | 26921389 | |
| Pubmed | Molecular mechanisms of polymorphic CYP3A7 expression in adult human liver and intestine. | 7.38e-06 | 2 | 95 | 2 | 11940601 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 12620808 | ||
| Pubmed | Robust visual cortex evoked potentials (VEP) in Gnat1 and Gnat2 knockout mice. | 7.38e-06 | 2 | 95 | 2 | 36605613 | |
| Pubmed | Functional interchangeability of rod and cone transducin alpha-subunits. | 7.38e-06 | 2 | 95 | 2 | 19815523 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 17928512 | ||
| Pubmed | Rod Photoreceptors Avoid Saturation in Bright Light by the Movement of the G Protein Transducin. | 7.38e-06 | 2 | 95 | 2 | 33593858 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 16683905 | ||
| Pubmed | Expression of CYP3A4 and CYP3A7 in Human Foetal Tissues and its Correlation with Nuclear Receptors. | 7.38e-06 | 2 | 95 | 2 | 25689036 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 27349315 | ||
| Pubmed | Transportin-mediated nuclear import of heterogeneous nuclear RNP proteins. | 7.38e-06 | 2 | 95 | 2 | 9298975 | |
| Pubmed | Developmental regulation of CYP3A4 and CYP3A7 in Chinese Han population. | 7.38e-06 | 2 | 95 | 2 | 27727071 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 12485945 | ||
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | 7.94e-06 | 621 | 95 | 10 | 22794259 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 9.16e-06 | 497 | 95 | 9 | 36774506 | |
| Pubmed | 1.15e-05 | 183 | 95 | 6 | 23956138 | ||
| Pubmed | 1.29e-05 | 657 | 95 | 10 | 36180527 | ||
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | TNPO1 IPO5 NOP56 AP1B1 AP2B1 CTR9 UBR4 EIF4G1 SMARCA1 PTPN23 | 1.43e-05 | 665 | 95 | 10 | 30457570 |
| Pubmed | Inhibition of nuclear import mediated by the Rev-arginine rich motif by RNA molecules. | 2.21e-05 | 3 | 95 | 2 | 12614157 | |
| Pubmed | The HIV-1 Tat nuclear localization sequence confers novel nuclear import properties. | 2.21e-05 | 3 | 95 | 2 | 9430704 | |
| Pubmed | P23H opsin knock-in mice reveal a novel step in retinal rod disc morphogenesis. | 2.21e-05 | 3 | 95 | 2 | 24214395 | |
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 19801957 | ||
| Pubmed | Ventral striatum dopamine release encodes unique properties of visual stimuli in mice. | 2.21e-05 | 3 | 95 | 2 | 37067979 | |
| Pubmed | Metabolic pathways of inhaled glucocorticoids by the CYP3A enzymes. | 2.21e-05 | 3 | 95 | 2 | 23143891 | |
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 33866277 | ||
| Pubmed | Regulation of the human NBC3 Na+/HCO3- cotransporter by carbonic anhydrase II and PKA. | 2.21e-05 | 3 | 95 | 2 | 14736710 | |
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 20621111 | ||
| Pubmed | Contribution of three CYP3A isoforms to metabolism of R- and S-warfarin. | 2.21e-05 | 3 | 95 | 2 | 20615193 | |
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 22277676 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 3856323 | ||
| Pubmed | Spectral and temporal sensitivity of cone-mediated responses in mouse retinal ganglion cells. | 2.21e-05 | 3 | 95 | 2 | 21613480 | |
| Pubmed | Comparison of steroid hormone hydroxylation mediated by cytochrome P450 3A subfamilies. | 2.21e-05 | 3 | 95 | 2 | 32001245 | |
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 31537864 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 23266416 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 29847800 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 36123333 | ||
| Pubmed | ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import. | 2.21e-05 | 3 | 95 | 2 | 20606625 | |
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 32146629 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 31776212 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 12444018 | ||
| Pubmed | Association study of 45 candidate genes in nicotine dependence in Han Chinese. | 2.21e-05 | 3 | 95 | 2 | 22309839 | |
| Pubmed | Photoresponse diversity among the five types of intrinsically photosensitive retinal ganglion cells. | 2.21e-05 | 3 | 95 | 2 | 24396062 | |
| Pubmed | Restoration of vision after de novo genesis of rod photoreceptors in mammalian retinas. | 2.21e-05 | 3 | 95 | 2 | 30111842 | |
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 17582393 | ||
| Pubmed | Light-dependent pathways for dopaminergic amacrine cell development and function. | 2.21e-05 | 3 | 95 | 2 | 30403373 | |
| Pubmed | Phototransduction Influences Metabolic Flux and Nucleotide Metabolism in Mouse Retina. | 2.21e-05 | 3 | 95 | 2 | 26677218 | |
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 20118548 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 34688813 | ||
| Pubmed | Involvement of transportin 2-mediated HuR import in muscle cell differentiation. | 2.21e-05 | 3 | 95 | 2 | 17475777 | |
| Pubmed | 4.17e-05 | 70 | 95 | 4 | 15128046 | ||
| Pubmed | Detection of cytochrome P450 gene expression in human placenta in first trimester of pregnancy. | 4.41e-05 | 4 | 95 | 2 | 8694864 | |
| Pubmed | Role of activation of PIP5Kgamma661 by AP-2 complex in synaptic vesicle endocytosis. | 4.41e-05 | 4 | 95 | 2 | 17290217 | |
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 31333190 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 16704975 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 38183495 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 26238215 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 9891055 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 20603337 | ||
| Pubmed | Rod photoreceptors drive circadian photoentrainment across a wide range of light intensities. | 4.41e-05 | 4 | 95 | 2 | 20711184 | |
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 14592810 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 10875935 | ||
| Pubmed | Karyopherin beta 2B participates in mRNA export from the nucleus. | 4.41e-05 | 4 | 95 | 2 | 12384575 | |
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 35852587 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 34689350 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 18978522 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 29959210 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 17007050 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 12403779 | ||
| Pubmed | Golf: an olfactory neuron specific-G protein involved in odorant signal transduction. | 4.41e-05 | 4 | 95 | 2 | 2499043 | |
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 15507604 | ||
| Pubmed | Transportins 1 and 2 are redundant nuclear import factors for hnRNP A1 and HuR. | 4.41e-05 | 4 | 95 | 2 | 15037768 | |
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 30947334 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 9707615 | ||
| Pubmed | Molecular expression of SLC4-derived Na+-dependent anion transporters in selected human tissues. | 4.41e-05 | 4 | 95 | 2 | 17715183 | |
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 7534311 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | TNPO1 AP1B1 TELO2 XPO6 UBR4 EIF4G1 SLC19A2 LRRC40 SLC35B2 OPA1 COG8 | 5.34e-05 | 942 | 95 | 11 | 31073040 |
| Pubmed | 6.11e-05 | 151 | 95 | 5 | 17043677 | ||
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | 6.83e-05 | 498 | 95 | 8 | 36634849 | |
| Pubmed | 7.34e-05 | 5 | 95 | 2 | 24168324 | ||
| Interaction | SIGLECL1 interactions | 9.20e-07 | 113 | 93 | 7 | int:SIGLECL1 | |
| Interaction | C9orf78 interactions | TNPO1 IPO5 UBE4A AP1B1 AP2B1 TELO2 CTR9 TNPO2 EIF4G1 LRRC40 NUP160 OPA1 COG8 | 5.30e-06 | 620 | 93 | 13 | int:C9orf78 |
| Interaction | P2RY10 interactions | 9.66e-06 | 106 | 93 | 6 | int:P2RY10 | |
| Interaction | STIP1 interactions | TNPO1 IPO5 XRN2 NOP56 AP1B1 AP2B1 TELO2 KCNH2 CTR9 UBR4 EIF4G1 PTPN23 LRRC40 PKN2 SLC35B2 NUP160 | 1.34e-05 | 1006 | 93 | 16 | int:STIP1 |
| Interaction | VSIG2 interactions | 1.38e-05 | 32 | 93 | 4 | int:VSIG2 | |
| Interaction | CA14 interactions | 1.92e-05 | 71 | 93 | 5 | int:CA14 | |
| Interaction | TACSTD2 interactions | 2.96e-05 | 129 | 93 | 6 | int:TACSTD2 | |
| Interaction | MTNR1B interactions | 3.82e-05 | 135 | 93 | 6 | int:MTNR1B | |
| Cytoband | 22q12.2 | 2.44e-04 | 58 | 95 | 3 | 22q12.2 | |
| Cytoband | 1p13.1 | 2.15e-03 | 33 | 95 | 2 | 1p13.1 | |
| GeneFamily | Dyneins, axonemal | 3.64e-05 | 17 | 70 | 3 | 536 | |
| GeneFamily | Armadillo repeat containing|Importins | 4.35e-05 | 18 | 70 | 3 | 596 | |
| GeneFamily | Cytochrome P450 family 3 | 4.08e-04 | 8 | 70 | 2 | 1002 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 5.23e-04 | 9 | 70 | 2 | 1230 | |
| GeneFamily | Short chain dehydrogenase/reductase superfamily | 3.19e-03 | 76 | 70 | 3 | 743 | |
| GeneFamily | WD repeat domain containing | 3.46e-03 | 262 | 70 | 5 | 362 | |
| GeneFamily | Solute carriers | 4.23e-03 | 395 | 70 | 6 | 752 | |
| Coexpression | SAENZ_DETOX_PATHWAY_AND_CARCINOGENESIS_DN | 2.03e-05 | 15 | 95 | 3 | M1141 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | TNPO1 IPO5 UBE4A RIPOR2 SLC4A7 FAR2 NOP56 AP2B1 RRN3 TBC1D1 MARCHF6 LRRC40 NUP160 OPA1 COG8 | 3.04e-05 | 1215 | 95 | 15 | M41122 |
| Coexpression | GARY_CD5_TARGETS_DN | 3.20e-05 | 440 | 95 | 9 | M13893 | |
| Coexpression | SAENZ_DETOX_PATHWAY_AND_CARCINOGENESIS_DN | 5.03e-05 | 20 | 95 | 3 | MM1104 | |
| Coexpression | GSE13485_DAY1_VS_DAY7_YF17D_VACCINE_PBMC_UP | 6.07e-05 | 186 | 95 | 6 | M3295 | |
| Coexpression | HASLINGER_B_CLL_WITH_11Q23_DELETION | 7.75e-05 | 23 | 95 | 3 | M11509 | |
| Coexpression | GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY7_UP | 9.05e-05 | 200 | 95 | 6 | M9336 | |
| Coexpression | GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_PDC_DN | 9.05e-05 | 200 | 95 | 6 | M5005 | |
| Coexpression | GSE360_L_DONOVANI_VS_L_MAJOR_DC_UP | 9.05e-05 | 200 | 95 | 6 | M5192 | |
| Coexpression | GSE40666_WT_VS_STAT1_KO_CD8_TCELL_UP | 9.05e-05 | 200 | 95 | 6 | M9205 | |
| Coexpression | GSE17721_CPG_VS_GARDIQUIMOD_1H_BMDC_UP | 9.05e-05 | 200 | 95 | 6 | M3878 | |
| ToppCell | LAM-Epithelial-AirwayEpi|LAM / Condition, Lineage and Cell class | 1.86e-07 | 192 | 95 | 7 | 7404fc65be3b7bd09447725b43fa31819004dfee | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_GPR21|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.01e-06 | 174 | 95 | 6 | 0df738309b7b6e77675ea74e7a87e66601b0073d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.14e-06 | 176 | 95 | 6 | dee780cfa85234a7cd7bf440b66b84cec959893e | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-06 | 189 | 95 | 6 | de51fbd6fdb24fc4549393cf41a020005444b2aa | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.33e-06 | 190 | 95 | 6 | 1d8e169d2448a34180c415843bb49aa45ed540c5 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.44e-06 | 191 | 95 | 6 | 7b5da29109aa28768c67653a1bc0f385c2d2269b | |
| ToppCell | Control-Epithelial-Ciliated_cells|Control / Condition, Lineage and Cell class | 3.44e-06 | 191 | 95 | 6 | ea1d2c6838119b7019e9a2ff71d6212262b51b57 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.44e-06 | 191 | 95 | 6 | b4e335e798c9617356b8e24412f9270c42dce656 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.44e-06 | 191 | 95 | 6 | e81cd65dbf0ef1c2ab7088f73ce605d456dd3a7a | |
| ToppCell | Control-Epithelial-Ciliated|Control / Disease group,lineage and cell class （2021.01.30） | 3.44e-06 | 191 | 95 | 6 | cdc08e95a0c8f5c7a8d01b6bbaafdb54ef2f0d12 | |
| ToppCell | Control-Epithelial|Control / Condition, Lineage and Cell class | 3.44e-06 | 191 | 95 | 6 | 6228302febdb3dffe37dece7062d27ac9ccc6d4b | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.65e-06 | 193 | 95 | 6 | 1043b28503bfaa0d5a82ec358bc86cbde73ea8f2 | |
| ToppCell | LAM-Epithelial-AirwayEpi|Epithelial / Condition, Lineage and Cell class | 3.65e-06 | 193 | 95 | 6 | f2672d2c495ee12c3b7d132452bde581fa5a7856 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.76e-06 | 194 | 95 | 6 | 756082a0f5953b52229bb60d40b84701cb6cb23d | |
| ToppCell | 3'-Distal_airway|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.76e-06 | 194 | 95 | 6 | e9ff4398e880d13894e52c0ba9cf19a7662c248b | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|COVID-19 / Condition, Lineage and Cell class | 3.76e-06 | 194 | 95 | 6 | 43be5fbd51dd58839cb03ca3ddd05a458e1ddb74 | |
| ToppCell | 3'-Distal_airway-Epithelial|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.87e-06 | 195 | 95 | 6 | 72fa2ba064055e2fee2b2cb8633c8f9a3c4373da | |
| ToppCell | 15-Trachea|15 / Age, Tissue, Lineage and Cell class | 3.99e-06 | 196 | 95 | 6 | fd17403422cf95c24f6be1c2d78764bb352f7f2e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.11e-06 | 197 | 95 | 6 | d83c61d2b5742e463122e1a98c7197a5b5b3d41b | |
| ToppCell | 18-Airway|18 / Age, Tissue, Lineage and Cell class | 4.23e-06 | 198 | 95 | 6 | 3cdfcc6445858c3c54058bbd90b20b88b1771cca | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.23e-06 | 198 | 95 | 6 | d0ecace1fad24ce50b0935036fabb07e6c9e372d | |
| ToppCell | BAL-Mild-Epithelial-Epithelial|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.35e-06 | 199 | 95 | 6 | 1ee4010d8557564e25e8ee00b914c2dfd9037838 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.35e-06 | 199 | 95 | 6 | 1df69c0cb5f759f6a2152521842506a75bb95cae | |
| ToppCell | Mild-Epithelial-Epithelial-|Mild / Condition, Lineage, Cell class and cell subclass | 4.35e-06 | 199 | 95 | 6 | 81115bbd2c10bfdd38376d2075f03a59c31870d2 | |
| ToppCell | BAL-Mild-Epithelial|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.35e-06 | 199 | 95 | 6 | 74087b4b5e567310fc4ac58fb267ff651a180680 | |
| ToppCell | BAL-Mild-Epithelial|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.35e-06 | 199 | 95 | 6 | 00b5ce099c50a5e1786ce2b3a06ee0931a8205a4 | |
| ToppCell | Mild-Epithelial|Mild / Condition, Lineage, Cell class and cell subclass | 4.35e-06 | 199 | 95 | 6 | ec5fff80e2a8a94fbaf1fdcc6d45c8d7c6252e18 | |
| ToppCell | Mild-Epithelial-Epithelial|Mild / Condition, Lineage, Cell class and cell subclass | 4.35e-06 | 199 | 95 | 6 | 91308b255783ad4029e5575028c18d7550832c51 | |
| ToppCell | Mild_COVID-19-Epithelial|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 4.35e-06 | 199 | 95 | 6 | 72689bda7476930887ae007682fcab27f956f050 | |
| ToppCell | Ciliated_cells-A-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 1.81e-05 | 151 | 95 | 5 | 9d03ce73af15ef40c592d19b36aff46bebc14c40 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 2.12e-05 | 156 | 95 | 5 | 10d191e29b16cae8238e8df6c0ff38882253f34e | |
| ToppCell | facs-Kidney-nan-3m-Lymphocytic|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-05 | 165 | 95 | 5 | ba041deb0d9c187f251493ccd4794b5f09abd5aa | |
| ToppCell | facs-Heart-LA-3m-Lymphocytic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-05 | 168 | 95 | 5 | 16c3313c4186fa327d71215f8eebc31fc12ff1c0 | |
| ToppCell | facs-Heart-LA-3m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-05 | 168 | 95 | 5 | 24d1e0a05cda09ee3b80208d75cb2b601023f3bf | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.02e-05 | 168 | 95 | 5 | ade02beb8d663fce4be2aefa10392ab849a4bbe7 | |
| ToppCell | facs-Lung-EPCAM-3m-Lymphocytic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-05 | 168 | 95 | 5 | 68ef5d1043fca804032669bf990edf110d65cf63 | |
| ToppCell | facs-Heart-LA-3m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-05 | 168 | 95 | 5 | b952af95a68888adedd03b1b60836d18524611ab | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.11e-05 | 169 | 95 | 5 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.11e-05 | 169 | 95 | 5 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.29e-05 | 171 | 95 | 5 | 5efd15300f865ebf651e0888265cbd717bc3b9d3 | |
| ToppCell | TCGA-Head_and_Esophagus-Solid_Tissue_Normal-Head_and_Neck-Head_and_Neck_normal_tissue-5|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 3.38e-05 | 172 | 95 | 5 | 6b8a8d3b97c10b9d092307eed3cacbd2745df185 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_GPR21|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.77e-05 | 176 | 95 | 5 | ed7ba2a3af3b060dec98b60f09f96000a67f7e63 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.77e-05 | 176 | 95 | 5 | de746cdf2c777eec88cb03863e128e97ad6e8fb0 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.87e-05 | 177 | 95 | 5 | 64fbf799e7b0c4003b2f486cc41b0f7e7c11ea0c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.87e-05 | 177 | 95 | 5 | 64b8f665fdaf975558af2ad7d9b54d206de8350c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.98e-05 | 178 | 95 | 5 | de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6 | |
| ToppCell | Ciliated_cells-A-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 4.09e-05 | 179 | 95 | 5 | 0e6c22de2e3fb0ff23b3301863cf4011c5c59dff | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.09e-05 | 179 | 95 | 5 | 8498f94202434b3cb5d84f1a37d3ad191baf664e | |
| ToppCell | facs-SCAT|facs / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.20e-05 | 180 | 95 | 5 | 6c70b6b7480507fa94625013222ad338ee7dd1d9 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_NK-T_NK-ILC_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.20e-05 | 180 | 95 | 5 | 27672ac6a02172a31851f18decb9acffa8f5a703 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.20e-05 | 180 | 95 | 5 | 7a9aa96fb8035020640cc7d3df0c41c730516c6f | |
| ToppCell | 368C-Epithelial_cells-Epithelial-F_(Ciliated)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.31e-05 | 181 | 95 | 5 | 5a4574f1bfd0b4ca78da7effda43420857e17296 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.31e-05 | 181 | 95 | 5 | 13270b6ba6a9c8e5681c6f40000c643ce1d9344a | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_IL7R|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.31e-05 | 181 | 95 | 5 | 3e3c903b522dced6bec5dc447cc3f8bf9a9749e3 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-F_(Ciliated)|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.31e-05 | 181 | 95 | 5 | a4e891603645f694687e68e585744ddc1a3c8697 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 4.42e-05 | 182 | 95 | 5 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 4.42e-05 | 182 | 95 | 5 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | Ciliated_cells-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 4.42e-05 | 182 | 95 | 5 | e93968f800bfeb258e4e834fc8bf92d1cb72cd73 | |
| ToppCell | Ciliated_cells-A-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 4.66e-05 | 184 | 95 | 5 | 07c5a9633ccdcd18771e3230d6198a55c400afa6 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.66e-05 | 184 | 95 | 5 | 5daff849625f2f41d56615569c0ed59cd733b34c | |
| ToppCell | Ciliated_cells-A-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 4.78e-05 | 185 | 95 | 5 | d77ca57b02125a3a57a37f4aed20c89803b7d551 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.78e-05 | 185 | 95 | 5 | a2cae8c657e4f4d121476798e424876f7e247973 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 4.78e-05 | 185 | 95 | 5 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.78e-05 | 185 | 95 | 5 | 3e39a3cb534dfe2301930f3e2f7e8cefb522c158 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 4.78e-05 | 185 | 95 | 5 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.78e-05 | 185 | 95 | 5 | d50406a9a5b8d75110ba5985741aa2293950c543 | |
| ToppCell | tumor_Lung-Epithelial_cells-tS3|Epithelial_cells / Location, Cell class and cell subclass | 5.03e-05 | 187 | 95 | 5 | 3cea677279e71fdb9879530dea10a5e6393beacd | |
| ToppCell | Ciliated_cells-B-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 5.03e-05 | 187 | 95 | 5 | 6fa38dbccca36bc7a4fef46de74c6688f599f421 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.03e-05 | 187 | 95 | 5 | 9e10ed56090d82589bc457788282f664b70ace4b | |
| ToppCell | facs-Heart-RA-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.16e-05 | 188 | 95 | 5 | 4ddb11a90bf3baa7237bde304db44dfcc56aed52 | |
| ToppCell | facs-Heart-RA-3m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.16e-05 | 188 | 95 | 5 | e47e66906922d5c69b1aafe28face0787d3fc563 | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 5.16e-05 | 188 | 95 | 5 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 5.16e-05 | 188 | 95 | 5 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.16e-05 | 188 | 95 | 5 | 2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.29e-05 | 189 | 95 | 5 | 68a3cf7763d6f9b95d6d6524eff7a16042703f1d | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 5.29e-05 | 189 | 95 | 5 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 5.29e-05 | 189 | 95 | 5 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | Epithelial_cells-Ciliated_cells-A|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 5.43e-05 | 190 | 95 | 5 | 549d813a8f23b175875e53347928941f143e236c | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.43e-05 | 190 | 95 | 5 | 17829f4de31b3d9e4d71ba4817d18842aa699773 | |
| ToppCell | Ciliated_cells-A|World / lung cells shred on cell class, cell subclass, sample id | 5.43e-05 | 190 | 95 | 5 | cd87731aaa7d252424f79cfce9f7931457f17bdf | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.56e-05 | 191 | 95 | 5 | 2a8e6d560907e71e9f6e190ca0667da804e25641 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.56e-05 | 191 | 95 | 5 | 46c9d4d10c66c0fae1fa351924091b69ea2f38d4 | |
| ToppCell | BAL-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.56e-05 | 191 | 95 | 5 | 9f19098f260d5542aa8ba7eb6f91b44d0db6e0a4 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.56e-05 | 191 | 95 | 5 | fa9f8b50bfc7911c858bc2f9dcd204873d97ac61 | |
| ToppCell | Healthy_Control-Epithelial-Epithelial-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 5.56e-05 | 191 | 95 | 5 | 28caedb2e448e0c7f494100d714fa7cdcf150691 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.56e-05 | 191 | 95 | 5 | c4b223b33c020a064f576711a3d700eb60a2d737 | |
| ToppCell | Mild_COVID-19-Epithelial-Ciliated|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 5.56e-05 | 191 | 95 | 5 | 995e76bbf07674d95b8ef09e078cf6410af27a09 | |
| ToppCell | BAL-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.56e-05 | 191 | 95 | 5 | 5129f778a9283bfac4ff322c21c5ca71da4b7174 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.56e-05 | 191 | 95 | 5 | 3387b95a3f2445c672d407922fdce3a91eabaef8 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.56e-05 | 191 | 95 | 5 | a37f20172b85566b9039254a89680e37fd503fd5 | |
| ToppCell | BAL-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.56e-05 | 191 | 95 | 5 | df8a1a6e78aa0cb941b94cb676bd6891d79f3687 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.56e-05 | 191 | 95 | 5 | 2d36e08c5629cf73b6dd02cd173cafb52e8a3a7d | |
| ToppCell | Healthy_Control-Epithelial-Epithelial|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 5.56e-05 | 191 | 95 | 5 | 15b9386b26caaa7d15f704c4a18881e1ce918a21 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.56e-05 | 191 | 95 | 5 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | Control-Epithelial|Control / Disease group,lineage and cell class （2021.01.30） | 5.56e-05 | 191 | 95 | 5 | b78547dae8328244a47c83346447bdd787efbcae | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.56e-05 | 191 | 95 | 5 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | Healthy_Control-Epithelial|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 5.56e-05 | 191 | 95 | 5 | fdcdadbfc9ccae175abe4de8c7428ac4f6a67fde | |
| ToppCell | BAL-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.56e-05 | 191 | 95 | 5 | c50d6a1a6209ed4157f7c00fc24d4ecb43790f44 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.56e-05 | 191 | 95 | 5 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | (1)_Control_(PBS)-(1)_VE-Cad+_vascular_cells|(1)_Control_(PBS) / Stress and Cell class | 5.70e-05 | 192 | 95 | 5 | e16e49b302019474232ef4cc0ff217d33afe34cf | |
| Computational | Cytochrome P450. | 5.20e-05 | 14 | 58 | 3 | MODULE_106 | |
| Drug | chloral | 6.11e-07 | 73 | 95 | 6 | CID000006407 | |
| Drug | TFPAM-6 | 1.39e-06 | 6 | 95 | 3 | CID000132237 | |
| Drug | 1,1,1-trichloroethane | 4.13e-06 | 156 | 95 | 7 | CID000006278 | |
| Drug | BP-9,10-oxide | 4.64e-06 | 27 | 95 | 4 | CID000037456 | |
| Drug | Brn 4136738 | 4.64e-06 | 27 | 95 | 4 | CID000050331 | |
| Drug | C14845 | 4.64e-06 | 27 | 95 | 4 | CID011954064 | |
| Drug | 1,1-dichloroethylene | 5.18e-06 | 60 | 95 | 5 | CID000006366 | |
| Drug | 9-OH-BaP-4,5-oxide | 5.39e-06 | 28 | 95 | 4 | CID000115064 | |
| Drug | 19-hydroxytestosterone | 7.17e-06 | 30 | 95 | 4 | CID000150968 | |
| Drug | 11-H-14,15-EETA | 7.17e-06 | 30 | 95 | 4 | CID011954058 | |
| Drug | BP-7,8-oxide | 9.35e-06 | 32 | 95 | 4 | CID000037455 | |
| Drug | 4-bromophenol | 1.11e-05 | 70 | 95 | 5 | CID000007808 | |
| Drug | 12(13)-EpOME | 1.20e-05 | 34 | 95 | 4 | CID000001416 | |
| Drug | TCEO | 1.20e-05 | 34 | 95 | 4 | CID000028167 | |
| Drug | AC1O5XSP | 1.20e-05 | 34 | 95 | 4 | CID006442739 | |
| Drug | AC1L1CJI | 1.35e-05 | 35 | 95 | 4 | CID000001929 | |
| Drug | 15-H-11,12-EETA | 1.51e-05 | 36 | 95 | 4 | CID011954042 | |
| Drug | AC1L3NGJ | 1.51e-05 | 36 | 95 | 4 | CID000092121 | |
| Drug | chloral hydrate | 1.69e-05 | 129 | 95 | 6 | CID000002707 | |
| Drug | Solanine alpha [20562-02-1]; Up 200; 4.6uM; HL60; HT_HG-U133A | 1.78e-05 | 195 | 95 | 7 | 2152_UP | |
| Drug | Skatole | 1.95e-05 | 13 | 95 | 3 | ctd:D012862 | |
| Drug | Lithocholic acid [434-13-9]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 1.96e-05 | 198 | 95 | 7 | 3433_UP | |
| Drug | Paroxetine maleate [64006-44-6]; Up 200; 1uM; MCF7; HT_HG-U133A | 1.96e-05 | 198 | 95 | 7 | 4378_UP | |
| Drug | Alverine citrate salt [5560-59-8]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 2.02e-05 | 199 | 95 | 7 | 2273_DN | |
| Drug | Furaltadone hydrochloride [3759-92-0]; Up 200; 11uM; MCF7; HT_HG-U133A | 2.02e-05 | 199 | 95 | 7 | 3932_UP | |
| Drug | 11,14,15-THET | 2.09e-05 | 39 | 95 | 4 | CID006439531 | |
| Drug | 11,12,15-trihydroxyeicosatrienoic acid | 2.82e-05 | 42 | 95 | 4 | CID006439610 | |
| Drug | 4-ipomeanol | 3.09e-05 | 15 | 95 | 3 | CID000036284 | |
| Drug | naphthalene-1,2-dihydrodiol | 3.72e-05 | 45 | 95 | 4 | CID000000362 | |
| Drug | C14802 | 4.42e-05 | 47 | 95 | 4 | CID011954053 | |
| Drug | nitro-L | 4.81e-05 | 48 | 95 | 4 | CID000006849 | |
| Drug | C14800 | 4.81e-05 | 48 | 95 | 4 | CID011954051 | |
| Drug | AC1NA07U | 4.90e-05 | 95 | 95 | 5 | CID004369512 | |
| Drug | halothane | 5.14e-05 | 314 | 95 | 8 | CID000003562 | |
| Drug | ivabradine | 5.15e-05 | 3 | 95 | 2 | ctd:C088408 | |
| Drug | 4-(dimethylamino)benzoic acid | 5.15e-05 | 3 | 95 | 2 | CID000012092 | |
| Drug | 17-hydroxypregnenolone sulfate | 5.15e-05 | 3 | 95 | 2 | CID000152971 | |
| Drug | 19-HETE | 5.22e-05 | 49 | 95 | 4 | CID006439528 | |
| Drug | bromobenzene-3,4-oxide | 5.22e-05 | 49 | 95 | 4 | CID000108121 | |
| Drug | bromobenzene-2,3-oxide | 5.65e-05 | 50 | 95 | 4 | CID003036760 | |
| Drug | 6-hydroxymelatonin | 5.65e-05 | 50 | 95 | 4 | CID000001864 | |
| Drug | 1,1-dichloroethylene epoxide | 5.65e-05 | 50 | 95 | 4 | CID000119521 | |
| Drug | sertindole | 5.65e-05 | 50 | 95 | 4 | CID000060149 | |
| Drug | naphthalene epoxide | 6.12e-05 | 51 | 95 | 4 | CID000108063 | |
| Drug | AC1Q6O3S | 6.50e-05 | 19 | 95 | 3 | CID000071338 | |
| Drug | C22H22O8 | 6.52e-05 | 164 | 95 | 6 | CID000004865 | |
| Drug | 9-hydroxybenzo(a)pyrene | 7.12e-05 | 53 | 95 | 4 | CID000028598 | |
| Drug | dichloroacetaldehyde | 7.67e-05 | 54 | 95 | 4 | CID000006576 | |
| Drug | chloroacetyl chloride | 8.24e-05 | 55 | 95 | 4 | CID000006577 | |
| Drug | 1,2-dihydroxynaphthalene | 9.48e-05 | 57 | 95 | 4 | CID000011318 | |
| Drug | bromoacetaldehyde | 1.02e-04 | 58 | 95 | 4 | CID000105131 | |
| Drug | desmethylastemizole | 1.03e-04 | 4 | 95 | 2 | CID000155805 | |
| Drug | 3-methyleneindolenine | 1.03e-04 | 4 | 95 | 2 | ctd:C097745 | |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A | 1.19e-04 | 183 | 95 | 6 | 6925_DN | |
| Drug | BP-4,5-oxide | 1.24e-04 | 61 | 95 | 4 | CID000037786 | |
| Drug | Bis-GMA | 1.34e-04 | 24 | 95 | 3 | CID000015284 | |
| Drug | pentachlorophenol | 1.48e-04 | 120 | 95 | 5 | CID000000992 | |
| Drug | DB08668 | 1.58e-04 | 65 | 95 | 4 | CID011840990 | |
| Drug | Coralyne chloride hydrate [38989-38-7]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 1.64e-04 | 194 | 95 | 6 | 5418_UP | |
| Drug | geldanamycin; Down 200; 1uM; HL60; HT_HG-U133A | 1.64e-04 | 194 | 95 | 6 | 1169_DN | |
| Drug | naphthalene | 1.67e-04 | 123 | 95 | 5 | CID000000931 | |
| Drug | Piracetam [7491-74-9]; Up 200; 28.2uM; MCF7; HT_HG-U133A | 1.69e-04 | 195 | 95 | 6 | 2861_UP | |
| Drug | Thiocolchicoside [602-41-5]; Down 200; 7uM; HL60; HG-U133A | 1.69e-04 | 195 | 95 | 6 | 1726_DN | |
| Drug | mosapride | 1.71e-04 | 26 | 95 | 3 | CID000119583 | |
| Drug | 4-ipomeanol | 1.71e-04 | 5 | 95 | 2 | ctd:C001470 | |
| Drug | propoxyphene | 1.78e-04 | 67 | 95 | 4 | CID000010100 | |
| Drug | Bergenin monohydrate [477-90-7]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 1.78e-04 | 197 | 95 | 6 | 3467_UP | |
| Drug | Phenelzine sulfate [156-51-4]; Down 200; 17uM; MCF7; HT_HG-U133A | 1.78e-04 | 197 | 95 | 6 | 3884_DN | |
| Drug | DAPH; Down 200; 10uM; MCF7; HG-U133A | 1.78e-04 | 197 | 95 | 6 | 624_DN | |
| Drug | Ethionamide [536-33-4]; Up 200; 24uM; MCF7; HT_HG-U133A | 1.78e-04 | 197 | 95 | 6 | 4418_UP | |
| Drug | PNU-0230031 [267429-39-0]; Up 200; 1uM; MCF7; HT_HG-U133A | 1.78e-04 | 197 | 95 | 6 | 4757_UP | |
| Drug | Piperacillin sodium salt [59703-84-3]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 1.78e-04 | 197 | 95 | 6 | 3939_UP | |
| Drug | rapamycin; Down 200; 0.1uM; MCF7; HG-U133A | 1.78e-04 | 197 | 95 | 6 | 326_DN | |
| Drug | Cefaclor [70356-03-5]; Down 200; 10.4uM; HL60; HT_HG-U133A | 1.78e-04 | 197 | 95 | 6 | 2483_DN | |
| Drug | Oxolinic acid [14698-29-4]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 1.78e-04 | 197 | 95 | 6 | 5519_UP | |
| Drug | Atropine-N-oxide hydrochloride [4574-60-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.83e-04 | 198 | 95 | 6 | 2216_UP | |
| Drug | Alverine citrate salt [5560-59-8]; Down 200; 8.4uM; HL60; HG-U133A | 1.83e-04 | 198 | 95 | 6 | 1426_DN | |
| Drug | Melatonin [73-31-4]; Up 200; 17.2uM; MCF7; HT_HG-U133A | 1.83e-04 | 198 | 95 | 6 | 5393_UP | |
| Drug | (S)-(-)-Atenolol [93379-54-5]; Down 200; 15uM; MCF7; HT_HG-U133A | 1.83e-04 | 198 | 95 | 6 | 6444_DN | |
| Drug | Flunixin meglumine [42461-84-7]; Up 200; 8.2uM; MCF7; HT_HG-U133A | 1.88e-04 | 199 | 95 | 6 | 4735_UP | |
| Drug | Dantrolene sodium salt [14663-23-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.88e-04 | 199 | 95 | 6 | 3978_DN | |
| Drug | 5,6-epoxyeicosatrienoic acid | 1.89e-04 | 68 | 95 | 4 | CID000001778 | |
| Drug | Aspartic acid, N-acetyl (R,S) [997-55-7]; Up 200; 22.8uM; HL60; HT_HG-U133A | 1.94e-04 | 200 | 95 | 6 | 1329_UP | |
| Drug | 8(9)-EET | 2.00e-04 | 69 | 95 | 4 | CID000001901 | |
| Drug | 1h1q | 2.11e-04 | 70 | 95 | 4 | CID000001540 | |
| Drug | 1,2-dibromoethane | 2.23e-04 | 71 | 95 | 4 | CID000007839 | |
| Drug | carteolol | 2.35e-04 | 72 | 95 | 4 | CID000002583 | |
| Drug | fexofenadine | 2.48e-04 | 73 | 95 | 4 | CID000003348 | |
| Drug | 2,2,2-trichloroethanol | 2.48e-04 | 73 | 95 | 4 | CID000008259 | |
| Drug | 5-Acetamido-5,6-Dihydro-4-Hydroxy-6-Isobutoxy-4h-Pyran-2-Carboxylic Acid | 2.48e-04 | 73 | 95 | 4 | CID011963505 | |
| Drug | HiTec | 2.56e-04 | 6 | 95 | 2 | CID000198177 | |
| Drug | Alfentanil | 2.56e-04 | 6 | 95 | 2 | ctd:D015760 | |
| Drug | Mefloquine | 2.56e-04 | 6 | 95 | 2 | ctd:D015767 | |
| Drug | C20H32O4 | 3.20e-04 | 78 | 95 | 4 | CID000001440 | |
| Drug | BP-7,8-diol | 3.20e-04 | 78 | 95 | 4 | CID000025892 | |
| Drug | AC1N8H7N | 3.20e-04 | 78 | 95 | 4 | CID004318740 | |
| Disease | intellectual developmental disorder with hypotonia, impaired speech, and dysmorphic facies (implicated_via_orthology) | 9.83e-06 | 2 | 93 | 2 | DOID:0081262 (implicated_via_orthology) | |
| Disease | anemia (implicated_via_orthology) | 1.34e-05 | 15 | 93 | 3 | DOID:2355 (implicated_via_orthology) | |
| Disease | Torsades de Pointes | 2.94e-05 | 3 | 93 | 2 | C0040479 | |
| Disease | Frontal Epilepsy, Benign, Childhood | 5.87e-05 | 4 | 93 | 2 | C0393671 | |
| Disease | Epilepsy, Cingulate | 5.87e-05 | 4 | 93 | 2 | C0393684 | |
| Disease | Epilepsy, Supplementary Motor | 5.87e-05 | 4 | 93 | 2 | C0393683 | |
| Disease | Epilepsy, Opercular | 5.87e-05 | 4 | 93 | 2 | C0393688 | |
| Disease | Epilepsy, Orbito-Frontal | 5.87e-05 | 4 | 93 | 2 | C0751643 | |
| Disease | Epilepsy, Anterior Fronto-Polar | 5.87e-05 | 4 | 93 | 2 | C0751642 | |
| Disease | Epilepsy, Frontal Lobe | 5.87e-05 | 4 | 93 | 2 | C0085541 | |
| Disease | tacrolimus measurement | 5.87e-05 | 4 | 93 | 2 | EFO_0008458 | |
| Disease | estrone conjugate measurement | 5.87e-05 | 4 | 93 | 2 | EFO_0007971 | |
| Disease | tauro-beta-muricholate measurement | 9.77e-05 | 5 | 93 | 2 | EFO_0800213 | |
| Disease | glyco-beta-muricholate measurement | 9.77e-05 | 5 | 93 | 2 | EFO_0800569 | |
| Disease | dehydroisoandrosterone sulfate DHEA-S measurement | 1.46e-04 | 6 | 93 | 2 | EFO_0021119 | |
| Disease | androstenediol (3beta,17beta) monosulfate (1) measurement | 1.46e-04 | 6 | 93 | 2 | EFO_0800294 | |
| Disease | X-24574 measurement | 2.04e-04 | 7 | 93 | 2 | EFO_0800897 | |
| Disease | McCune Albright syndrome (implicated_via_orthology) | 2.72e-04 | 8 | 93 | 2 | DOID:1858 (implicated_via_orthology) | |
| Disease | androstenediol (3beta,17beta) disulfate (1) measurement | 3.49e-04 | 9 | 93 | 2 | EFO_0800278 | |
| Disease | interleukin 17 measurement | 3.91e-04 | 45 | 93 | 3 | EFO_0008174 | |
| Disease | 4-androsten-3alpha,17alpha-diol monosulfate (3) measurement | 4.35e-04 | 10 | 93 | 2 | EFO_0022090 | |
| Disease | 5alpha-androstan-3beta,17alpha-diol disulfate measurement | 4.35e-04 | 10 | 93 | 2 | EFO_0800289 | |
| Disease | DNA repair protein RAD51 homolog 4 measurement | 5.31e-04 | 11 | 93 | 2 | EFO_0801531 | |
| Disease | androstenediol (3beta,17beta) monosulfate (2) measurement | 5.31e-04 | 11 | 93 | 2 | EFO_0800295 | |
| Disease | glucose-dependent insulinotropic peptide measurement | 6.33e-04 | 53 | 93 | 3 | EFO_0008464 | |
| Disease | temporal pole volume measurement | 6.35e-04 | 12 | 93 | 2 | EFO_0010334 | |
| Disease | 5alpha-androstan-3beta,17beta-diol monosulfate (2) measurement | 6.35e-04 | 12 | 93 | 2 | EFO_0800291 | |
| Disease | androstenediol (3alpha, 17alpha) monosulfate (3) measurement | 7.49e-04 | 13 | 93 | 2 | EFO_0800293 | |
| Disease | 5alpha-pregnan-3beta,20beta-diol monosulfate (1) measurement | 7.49e-04 | 13 | 93 | 2 | EFO_0800284 | |
| Disease | X-21470 measurement | 8.72e-04 | 14 | 93 | 2 | EFO_0800817 | |
| Disease | 5alpha-androstan-3alpha,17alpha-diol monosulfate measurement | 8.72e-04 | 14 | 93 | 2 | EFO_0800283 | |
| Disease | 16a-hydroxy DHEA 3-sulfate measurement | 1.00e-03 | 15 | 93 | 2 | EFO_0800301 | |
| Disease | platelet-to-lymphocyte ratio | 1.03e-03 | 363 | 93 | 6 | EFO_0008446 | |
| Disease | X-21410 measurement | 1.15e-03 | 16 | 93 | 2 | EFO_0800813 | |
| Disease | andro steroid monosulfate C19H28O6S (1) measurement | 1.15e-03 | 16 | 93 | 2 | EFO_0800305 | |
| Disease | 5alpha-androstan-3alpha,17beta-diol monosulfate (1) measurement | 1.45e-03 | 18 | 93 | 2 | EFO_0800288 | |
| Disease | sensorineural hearing loss (implicated_via_orthology) | 1.62e-03 | 19 | 93 | 2 | DOID:10003 (implicated_via_orthology) | |
| Disease | metabolonic lactone sulfate measurement | 1.62e-03 | 19 | 93 | 2 | EFO_0800659 | |
| Disease | etiocholanolone glucuronide measurement | 1.62e-03 | 19 | 93 | 2 | EFO_0800362 | |
| Disease | androsterone glucuronide measurement | 1.80e-03 | 20 | 93 | 2 | EFO_0800317 | |
| Disease | lymphocyte count | TNPO1 CYP3A7 RIPOR2 NWD1 SLC4A7 CYP3A4 XPO6 TBC1D1 DNAH17 PKN2 SFI1 NUP160 | 2.15e-03 | 1464 | 93 | 12 | EFO_0004587 |
| Disease | depressive disorder (implicated_via_orthology) | 2.18e-03 | 22 | 93 | 2 | DOID:1596 (implicated_via_orthology) | |
| Disease | X-24947 measurement | 2.18e-03 | 22 | 93 | 2 | EFO_0800910 | |
| Disease | 5alpha-androstan-3beta,17beta-diol disulfate measurement | 2.18e-03 | 22 | 93 | 2 | EFO_0021115 | |
| Disease | epiandrosterone sulfate measurement | 2.81e-03 | 25 | 93 | 2 | EFO_0021120 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ATIQTAMAILQDLRQ | 366 | A0A096LP49 | |
| IMIRLASQANIAQVL | 341 | P63010 | |
| IMIRLASQANIAQVL | 341 | Q10567 | |
| IQDLTNMVRELLIQF | 641 | Q9HCK5 | |
| TSLRIRIVNFVVMNN | 116 | A1A5B4 | |
| ALVQATSFLQNILQM | 366 | Q5JU67 | |
| QRVLLFSQSRQMLDI | 856 | Q03468 | |
| QLAGLRLLTNMTVTN | 221 | Q9UH62 | |
| QQMIQLLLAAARRTL | 501 | Q149M9 | |
| LTIIRLINDNFQIMS | 196 | P24903 | |
| LRANMTNVFIVSLAV | 71 | P21918 | |
| RQILTLNVNLMLGQA | 171 | Q9H3S7 | |
| QLNVTATRQLLLMAS | 126 | Q96K12 | |
| VNRVDNMIIQSISLL | 161 | O00567 | |
| RTLQTLEIQLQSLMA | 311 | Q7Z3Y7 | |
| QVLFSRNMRLNVALT | 156 | Q9H079 | |
| MNLRSVFTVEQQRIL | 1 | Q7Z353 | |
| SIQIRFIQNMIQETL | 586 | Q8NHV4 | |
| SILAIVRAMTTLNIQ | 76 | P11488 | |
| ALLTLYISRQTAQQM | 231 | Q96FN5 | |
| ILRTQSAMFNQVLIL | 241 | Q5JUK3 | |
| LSADMATVLQLLQRQ | 1056 | Q12809 | |
| NMKLALIRVLQNFSF | 451 | P08684 | |
| SALQQQLLLMVARRT | 766 | A6NKB5 | |
| RLANINFLQDLALMI | 516 | Q9HCI6 | |
| RVTQLMSQEANLLLA | 451 | O75037 | |
| QLMLSQLIQQLRTNI | 206 | Q96MW5 | |
| TVLVQEMERFNNLII | 2851 | Q6ZR08 | |
| INFLDQLSLVVRTMQ | 121 | Q14657 | |
| VVVLMAILSFQVRQF | 856 | O60337 | |
| IQNVSSSDLLMLLRQ | 801 | P00451 | |
| ISNVRLARVMLTQFA | 446 | Q96RR1 | |
| TENQMFAARVVILLL | 196 | Q8NGU4 | |
| LNNMQRQLALEVIVT | 271 | O00410 | |
| MARAQALVLALTFQL | 1 | Q92729 | |
| MRQINQTQVTEFLLL | 1 | Q9H210 | |
| RQVLAFILMVFLSQV | 11 | Q9Y5E5 | |
| MRNVTNILIVNLSFS | 71 | P25929 | |
| MLAITANTLRQQLTN | 886 | O60313 | |
| LVALNFQTLDVAMQL | 671 | Q01970 | |
| AQQNMSLAILRIIRL | 331 | Q16322 | |
| LALLLQQFQTLKMRI | 656 | Q6Y7W6 | |
| AFIISVMLIAANQVL | 196 | Q86V35 | |
| ISQLNVLITLLMGNL | 1731 | Q9UFH2 | |
| LITSLQILQMFVGAI | 201 | Q9HB03 | |
| LQIAITFNLVTAMAV | 56 | Q13520 | |
| IFNTVLAMIRTRIQI | 526 | O43909 | |
| TVLMFNVALVLQRLA | 751 | Q6PD62 | |
| LEIQTTLRNILQTMV | 46 | Q9NSG2 | |
| TLRNILQTMVQLLGA | 51 | Q9NSG2 | |
| FLLLTISLLVMVQIQ | 6 | P31358 | |
| QQIVSNTLVRALMTA | 1471 | Q04637 | |
| VSLAQLSQVSVLMRN | 591 | Q9UH90 | |
| MNRQLVNILTALFAF | 1 | P23416 | |
| SDLTLLMQQRLVSFQ | 216 | P13584 | |
| AQLTFQILLMNREVN | 3756 | Q9NYC9 | |
| MISRRTGQIVLVNNI | 166 | A6NNS2 | |
| NMKLALVRVLQNFSF | 451 | P24462 | |
| MLLITIATFQIAANL | 401 | O60779 | |
| LQQVVTMGLFRTIAL | 291 | Q06136 | |
| MESLVRLQTINLSFN | 491 | Q9H9A6 | |
| SFLQAENLILRLQMQ | 16 | Q6ZR62 | |
| VAELTTSLMLQRLQQ | 111 | Q9H0K4 | |
| LQSLNFERIVMSQLN | 486 | Q9NYV6 | |
| QMQTTALEFRQRIIL | 206 | A8K8P3 | |
| LIFMDQQITAVIINR | 926 | Q9Y6M7 | |
| QGSRVLIFSQMTRLL | 501 | P28370 | |
| QVPTQMSFLFRLINI | 661 | Q8TEL6 | |
| MSFLFRLINIIHVQT | 666 | Q8TEL6 | |
| LLQNTALEVFMANRT | 2221 | Q8NFP9 | |
| ILNTNLRQIMVISVL | 26 | Q9Y227 | |
| NVLQSILAIIRAMTT | 76 | P19087 | |
| QFVMTQKLLFLQSRL | 296 | Q9Y4R8 | |
| ITMLILVTANNLFQL | 126 | P03915 | |
| LIFMDQQITAVIINR | 796 | Q2Y0W8 | |
| RMQILQAVQTNELAF | 191 | Q16513 | |
| ETQNRVIILMLTNQT | 146 | Q12769 | |
| LARQVSMVQTLQSLR | 906 | Q9Y4F9 | |
| SLLVNLRAMQNFLQL | 421 | Q01826 | |
| FMLILQIRIQLSEES | 11 | Q15399 | |
| RLLMNSLFVLVVLAQ | 321 | Q92959 | |
| AAMRILVVLLSNQSI | 1686 | Q8IZQ1 | |
| TFLLVTNVLLMNLLI | 961 | Q9NZQ8 | |
| LNDIFMNNVIVRLSQ | 116 | O43295 | |
| DSQFLVLMNRVLALI | 151 | Q8TB61 | |
| QRALTTMQIQVAGLL | 316 | Q9BSA4 | |
| NIAAALIQILTAIVM | 96 | Q69YW2 | |
| VEQLVARSNIMTLLF | 656 | O14787 | |
| ILIFMDQQITAVIIN | 826 | Q6U841 | |
| MLRDLTQNTVVSINF | 741 | Q9H0D6 | |
| IILQIQMYQLSRLLH | 931 | Q86TI0 | |
| MNLAISIALLLTVLQ | 1 | P04216 | |
| VGQRLLNSVLNTLIM | 131 | P49810 | |
| LNSLILLVLMNNVLT | 221 | Q9HBX9 | |
| NIEQLVARSNILTLM | 666 | Q92973 | |
| QLALVRQISSAMEQL | 541 | Q9ULT0 | |
| QLNINHMIQRIFLIT | 81 | Q14139 | |
| MSNVEQALFARLLLQ | 131 | Q14139 | |
| NLQVSMAVLLVQLAI | 586 | Q14139 | |
| AMLFQFVNVLLQVLV | 1021 | Q96QU8 | |
| IMAQSTSIQRIQRLI | 511 | Q5T4S7 | |
| QTLNLITMLAIRVLA | 376 | Q96IP4 | |
| FQNVVLVLLNMLDNV | 286 | Q6P5S2 |